Feb. 14, 2018 Price forecast | 2 weeks: 4.57% | 1 month: 5.77% | 3 months: 3.34%


XTNT stock forecast

Our latest prediction for Xtant Medical Holdings, Inc.'s stock price was made on the Feb. 14, 2018 when the stock price was at 4.78$.

In the short term (2weeks), XTNT's stock price should outperform the market by 4.57%. During that period the price should oscillate between -8.24% and +15.30%.

In the medium term (3months), XTNT's stock price should outperform the market by 3.34%. During that period the price should oscillate between -18.13% and +35.02%.


About Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. operates as a holding company, which supplies orthopedic and spine surgery products. The firm operates through its subsidiaries, Bacterin International, Inc. and X-spine Systems, Inc. Bacterin International develops, manufactures, and markets biologics products to domestic and international markets. Its products are bone graft, which are used in promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries; and custom surgical products used for allografts. X-spine Systems is a manufacturer of implants and instruments for surgery of the spine and sacroiliac joint. Its products are used for the treatment of degenerative spine disorders. The company was founded in 2006 and is headquartered in Belgrade, MT.

At the moment the company generates 73M USD in revenues.

On its last earning announcement, the company reported a loss of -19.98$ per share.

The book value per share is 0.78$

Xtant Medical Holdings, Inc. website


Three months stock forecastFeb. 14, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
73M 63.50% -6M -7.70% -42M -19.98 - - 9M 0.78 - - -1M